These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20497146)

  • 1. A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?
    Katz PO; Johnson DA; Levine D; Röhss K; Junghard O; Astrand M; Nagy P
    Aliment Pharmacol Ther; 2010 Aug; 32(3):443-7. PubMed ID: 20497146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.
    Katz PO; Ginsberg GG; Hoyle PE; Sostek MB; Monyak JT; Silberg DG
    Aliment Pharmacol Ther; 2007 Mar; 25(5):617-28. PubMed ID: 17305763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
    Sharma P; Johnson DA; Monyak JT; Illueca M
    Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis.
    Kahrilas PJ; Dent J; Lauritsen K; Malfertheiner P; Denison H; Franzén S; Hasselgren G
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1385-91. PubMed ID: 17950677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom resolution does not predict healing of erosive oesophagitis in Chinese.
    Cheung TK; Wong WM; Wong NY; Chan CK; Fung J; Yuen MF; Chan AO; Tong TS; Wong BC
    Digestion; 2007; 75(2-3):128-34. PubMed ID: 17671381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies.
    Laine L; Katz PO; Johnson DA; Ibegbu I; Goldstein MJ; Chou C; Rossiter G; Lu Y
    Aliment Pharmacol Ther; 2011 Jan; 33(2):203-12. PubMed ID: 21114792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis.
    Yaghoobi M; Padol S; Yuan Y; Hunt RH
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):583-90. PubMed ID: 20061959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study.
    Atug O; Giral A; Kalayci C; Dolar E; Isitan F; Oguz D; Ovunc O; Ozgur O; Soykan I; Simsek I; Unal S; Yenice N;
    Adv Ther; 2008 Jun; 25(6):552-66. PubMed ID: 18568450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole.
    Sheu BS; Chang WL; Cheng HC; Kao AW; Lu CC
    Am J Gastroenterol; 2008 Sep; 103(9):2209-14. PubMed ID: 18702650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial.
    Spechler SJ; Sharma P; Traxler B; Levine D; Falk GW
    Am J Gastroenterol; 2006 Sep; 101(9):1964-71. PubMed ID: 16848802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: is stringent control of gastric pH useful and practical in GERD?
    Kahrilas PJ
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():89-94; discussion 95-6. PubMed ID: 15456470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
    Koop H; Klein M; Bauer A; Arnold R
    Z Gastroenterol; 1988 Jul; 26(7):345-50. PubMed ID: 3223004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis.
    Sjöstedt S; Befrits R; Sylvan A; Harthon C; Jörgensen L; Carling L; Modin S; Stubberöd A; Toth E; Lind T
    Aliment Pharmacol Ther; 2005 Aug; 22(3):183-91. PubMed ID: 16091055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.
    Kahrilas PJ; Persson T; Denison H; Wernersson B; Hughes N; Howden CW
    Aliment Pharmacol Ther; 2014 Sep; 40(6):648-56. PubMed ID: 25039978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis.
    Sheu BS; Cheng HC; Chang WL; Chen WY; Kao AW
    Am J Gastroenterol; 2007 Nov; 102(11):2387-94. PubMed ID: 17850409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
    Devault KR; Johanson JF; Johnson DA; Liu S; Sostek MB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):852-9. PubMed ID: 16682260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.
    Junghard O; Hassan-Alin M; Hasselgren G
    Eur J Clin Pharmacol; 2002 Oct; 58(7):453-8. PubMed ID: 12389067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid control with esomeprazole and lansoprazole: a comparative dose-response study.
    Wilder-Smith C; Lind T; Lundin C; Nauclér E; Nilsson-Pieschl C; Röhss K
    Scand J Gastroenterol; 2007 Feb; 42(2):157-64. PubMed ID: 17327934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.